Robert Prins

22PUBLICATIONS
123CO-AUTHORS
Predictive and prognostic markersMolecular targetsBiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 13, 2026
A syngeneic murine glioma model recapitulates key molecular, immunologic, and functional features of human glioblastoma to enable therapeutic development.

|Oct 06, 2026
Neoadjuvant PD1 plus CTLA-4 immune checkpoint blockade in surgically resectable recurrent glioblastoma: a randomized surgical window-of-opportunity trial.

|May 20, 2026
Armored Chimeric Antigen Receptor T-cell Therapy Targets Antigen-Heterogeneous Glioma.

|May 13, 2026
Predictable clonal hierarchies from restricted progenitors provide a framework for cell type-specific therapies in glioblastoma.

|Jul 16, 2025
A Human Tumor-Immune Organoid Model of Glioblastoma.

Shivani Baisiwala, Elisa Fazzari, Matthew X Li

|Dec 31, 2024
Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort.

J Ricardo McFaline-Figueroa, Lu Sun, Gilbert C Youssef

Pageof 4

Frequent Collaborators

10 joint publications

Timothy F Cloughesy

10 joint publications

Richard G Everson

8 joint publications

Linda M Liau

5 joint publications

Alexander Lee